A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Retrograde Perfusion and Filling of Mouse Coronary Vasculature as Preparation for Micro Computed Tomography Imaging

32.9K views

⸱

DOI:

10.3791/3740

⸱

February 10th, 2012

 ,  ,  ,  , 

In This Article

Summary

Visualization of the coronary vessels is critical to advancing our understanding of cardiovascular diseases. Here we describe a method for perfusing murine coronary vasculature with a radiopaque silicone rubber (Microfil), in preparation for micro-Computed Tomography (μCT) imaging.

Abstract

Visualization of the vasculature is becoming increasingly important for understanding many different disease states. While several techniques exist for imaging vasculature, few are able to visualize the vascular network as a whole while extending to a resolution that includes the smaller vessels1,2. Additionally, many vascular casting techniques destroy the surrounding tissue, preventing further analysis of the sample3-5. One method which circumvents these issues is micro-Computed Tomography (μCT). μCT imaging can scan at resolutions <10 microns, is capable of producing 3D reconstructions of the vascular network, and leaves the tissue intact for subsequent analysis (e.g., histology and morphometry)6-11. However, imaging vessels by ex vivo μCT methods requires that the vessels be filled with a radiopaque compound. As such, the accurate representation of vasculature produced by μCT imaging is contingent upon reliable and complete filling of the vessels. In this protocol, we describe a technique for filling mouse coronary vessels in preparation for μCT imaging.

Two predominate techniques exist for filling the coronary vasculature: in vivo via cannulation and retrograde perfusion of the aorta (or a branch off the aortic arch) 12-14, or ex vivo via a Langendorff perfusion system 15-17. Here we describe an in vivo aortic cannulation method which has been specifically designed to ensure filling of all vessels. We use a low viscosity radiopaque compound called Microfil which can perfuse through the smallest vessels to fill all the capillaries, as well as both the arterial and venous sides of the vascular network. Vessels are perfused with buffer using a pressurized perfusion system, and then filled with Microfil. To ensure that Microfil fills the small higher resistance vessels, we ligate the large branches emanating from the aorta, which diverts the Microfil into the coronaries. Once filling is complete, to prevent the elastic nature of cardiac tissue from squeezing Microfil out of some vessels, we ligate accessible major vascular exit points immediately after filling. Therefore, our technique is optimized for complete filling and maximum retention of the filling agent, enabling visualization of the complete coronary vascular network – arteries, capillaries, and veins alike.

Protocol

1. Preparations before starting

  1. Fill each side of the pressure perfusion apparatus with Vasodilator buffer (4mg/L Papaverine + 1g/L Adenosine in PBS) or 4% Paraformaldehyde (PFA) in PBS, respectively.
  2. Prepare a 1/2cc Insulin Syringe (with a permanently attached 29G ½" needle) by filling it with 0.1 ml of 1:100 Heparin (5000U/ml stock) and bending the needle to ~120 degree angle with the bevel up. Do the same with a 1 ml syringe (with a 26G ½" needle) filled with 0.3 ml saturated KCl solution.

2. Exposing the heart and cannulating the aorta

  1. Anesthetize the mouse using your anesthetic of ch....

Access restricted. Please log in or start a trial to view this content.

Discussion

Cardiac tissue has a very high metabolic demand, and therefore requires a constant supply of nutrients and oxygen from the blood delivered by the coronary vasculature. Diseases of the coronary vessels, which decrease coronary function due to vessel stenosis and blockage, can lead to tissue hypoxia and ischemia, and put affected patients at risk for myocardial infarction and irreparable damage to the heart muscle. A better understanding of the diseased state of these vessels is necessary, and critical to our ability to st.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Mice were handled with methods approved by the Institutional Animal Care and Use Committee of the University of Washington and in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).

Acknowledgements

We thank Dr. Kelly Stevens for initial trials of the protocol, Dr. Michael Simons, Dr. Kip Hauch, and members of both of their labs for general discussion.

This work is support by NIH grants HL087513 and P01 HL094374.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
1 ml syringesfigure-materials-1 BD BiosciencesBD-309602
1/2cc insulin syringes with permanently attached 29G ½’ needlesfigure-materials-2 BD BiosciencesBD-309306
2" x 2" Gauze padsMed101store.comSKU 2208
24G ¾" Angiocath IV catheterfigure-materials-3 BD BiosciencesBD-381112
26G ½"gauge needlesfigure-materials-4 BD BiosciencesBD-305111
Adenosinefigure-materials-5 Sigma-AldrichA92511g/L in PBS for Vasodilation Buffer (with Papaverine)
Angled Graefe Forcepsfigure-materials-6 Fine Science Tools11052-10
Cotton-tipped applicators: 6" non-sterilefigure-materials-7 Cardinal HealthC15055-006
Curved Surgical Scissorsfigure-materials-8 Fine Science Tools14085-09
Dissecting stereoscope and light sourcefigure-materials-9 Nikon InstrumentsNANA
Dissecting Tray, 11.5 x 7.5 inchesfigure-materials-10 Cole-ParmerYO-10915-12Filled with tar for pinning down the mouse
Fine Curved Forcepsfigure-materials-11 AesculapFD281RNeed two
Heparin, 5000 U/ml stockfigure-materials-12 APP PharmaceuticalsNDC 63323-047-101:100 dilution in water
KClfigure-materials-13 Fisher ScientificP217Saturated solution in H2O
Ketamin (Ketaset), 100 mg/ml stockFort Dodge Animal HealthNDC 0856-2013-01Mixed as 130 mg/kg body weight, with Xylazine in 0.9% saline
Microfilfigure-materials-14 FlowTechMV-122 (yellow). Other color options are also available.Mix 1:1 by weight, with 10% by volume of curing agent. Prepare just before injection, and vortex to ensure it is well mixed
Non-sterile Suture: 6-0, braided silkfigure-materials-15 Harvard Apparatus723287
Papaverinefigure-materials-16 American Regent Inc.NDC 0517-4010-014mg/L in PBS for Vasodilation Buffer (with Adenosine)
Paraformaldehydefigure-materials-17 Sigma-AldrichP6148Prepared as 4% solution
Perfusion ApparatusSee figure 2
Spring Scissorsfigure-materials-18 Fine Science Tools15018-10
Xylazine (Anased), 20 mg/gl stockfigure-materials-19 Lloyd, Inc.NADA #139-236Mixed as 8.8 mg/kg body weight, with Ketamin in 0.9% saline

References

  1. Couffinhal, T., Dufourcq, P., Barandon, L., Leroux, L., Duplaa, C. Mouse models to study angiogenesis in the context of cardiovascular diseases. Front. Biosci. 14, 3310-3325 (2009).
  2. Zagorchev, L., Mulligan-Kehoe, M. J. Molecular imaging of vessels in mouse models of disease.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Micro CT ImagingAortic CannulationVasodilator BufferAFF FixativeVessel LigationMicrofil FillingPressure PerfusionHeart Dissection